Structure-based design of free fatty acid receptor 1 agonists bearing non-biphenyl scaffold.
Bioorg Chem
; 80: 296-302, 2018 10.
Article
en En
| MEDLINE
| ID: mdl-29980115
ABSTRACT
The free fatty acid receptor 1 (FFA1) enhances the glucose-stimulated insulin secretion without the risk of hypoglycemia. However, most of FFA1 agonists have a common biphenyl moiety, leading to a relative deprivation in structure types. Herein, we describe the exploration of non-biphenyl scaffold based on the co-crystal structure of FFA1 to increase additional interactions with the lateral residues, which led to the identification of lead compounds 3 and 9. In induced-fit docking study, compound 3 forms an edge-on interaction with Trp150 by slightly rotating the indole ring of Trp150, and compound 9 has additional hydrogen bond and δ-π interactions with Leu135, which demonstrated the feasibility of our design strategy. Moreover, lead compounds 3 and 9 revealed improved polar surface area compared to GW9508, and have considerable hypoglycemic effects in mice. This structure-based study might inspire us to design more promising FFA1 agonists by increasing additional interactions with the residues outside of binding pocket.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Diseño de Fármacos
/
Receptores Acoplados a Proteínas G
/
Hipoglucemiantes
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Bioorg Chem
Año:
2018
Tipo del documento:
Article